Staff members (REF1a/c)
1 - Clinical Medicine
University of Birmingham
- I - Immunology
- L - Neuroscience
- I - Immunology
- F - Endocrinology
- F - Endocrinology
Dr John Ayik is Consultant Endocrinologist and lead of the Pituitary Clinic at Queen Elizabeth Hospital Birmingham. His research interests are around Neuroendocrinology and Metabolic Bone Disease, and he works alongside Professor Weibke Arlt and Professor Jeremy Tomlinson at UoB on clinical research into pituitary disease including Cushing, hypopituitarism and acromegaly.
- G - Genetics & Epigenetics
- P - Virology
- P - Virology
- D - Cardiovascular
- J - Inflammation
- F - Endocrinology
- K - Microbiology
- B - Cancer Cell Biology
- P - Virology
- I - Immunology
- B - Cancer Cell Biology
- B - Cancer Cell Biology
- E - Clinical Trials
- F - Endocrinology
- H - Haematology
- I - Immunology
Richard J Burrows is Consultant Nephrologist at University Hospital Birmingham NHS Foundation Trust and Honorary Senior Lecturer at UoB. He has a particular interest in kidney transplantation and runs a productive research programme in the clinical and translation aspects of transplantation. He is the chief investigator for two longitudinal cohort studies in transplantation and supervises 3 reserach fellows (1 MD; 2 PhD). He works closely with Professor Lorraine Harper and Dr Matthew Morgan in the renal unit at UoB. He collaborates with Professor Paul Moss (Cancer Studies, UoB) on CMV and outcomes in kidney transplantation.
- D - Cardiovascular
- L - Neuroscience
- D - Cardiovascular
- J - Inflammation
- I - Immunology
- B - Cancer Cell Biology
- M - Reproduction
- J - Inflammation
- H - Haematology
- I - Immunology
Professor Paul Cockwell is Consultant Nephrologist at the University Hospital Birmingham NHS Foundation Trust and Honorary Professor of Nephrology in the School of Immunity and Infection, UoB. He is also Associate Director and Clinical Academic Group Lead for Chronic Disease, Informatics and Personalised Medicine and chairs the Birmingham Health Partners Research Strategy Committee. He works with Professor Mark Drayson, Director of Clinical Immunology Service and Professor Lorraine Harper in the renal unit. His research interests lie in Chronic Kidney Disease, Monoclonal Diseases, Dialysis Medicine, Kidney Transplantation. He works as a co-investigator with Professor Jon Deeks (School of Health and Population Sciences, UoB) and external collaborators on a major HTA grant (cystatin C) and Natalive Ives (School of Cancer Sciences, UoB) on a HTA-EME grant (stop ACE study). He holds grant funding money and co-supervises research fellows with Professor Iain Chapple (School of Dentistry) and Dr Melanie Calvert. He also collaborates with Professor Paul Moss (School of Cancer Sciences, UoB) on the impact of CMV on outcomes in CKD.
- B - Cancer Cell Biology
- M - Reproduction
- H - Haematology
- K - Microbiology
- B - Cancer Cell Biology
- P - Virology
- J - Inflammation
- I - Immunology
- D - Cardiovascular
- I - Immunology
Dr A M Elsharkawy is a Consultant Hepatologist at the University Hospital Birmingham NHS Foundation Trust and Honorary Research Fellow in the School of Immunity and Infection, UoB. He works closely with Professor David Adams, Director of the NIHR BRU and other staff based in the Centre for Liver Research on liver fibrosis, nutrition in liver disease and he leads on acute liver failure. He is a PI in current liver failure and liver support device trials.
- M - Reproduction
- D - Cardiovascular
- D - Cardiovascular
Dr Charles Ferro is Consultant Nephrologist at the University Hospital Birmingham NHS Foundation Trust and Honorary Senior Clinical Lecturer in Immunity and Infection at UoB, with a specialist interest in renal medicine. His main interests lie in the aetiology and treatment of cardiovascular disease in patients with chronic liver failure. He has an NIHR post doctoral fellowship and supervises 3 clinical PhD candidates. He is chief investigator or senior co-investigator on the Birmingham Cardio-Renal Group portfolio of studies, which evaluate different interventions in patients with CKD. CRIB-II, using spironolactone in early CKD was published in the Journal of the American College of Cardiology with much interest. This has been followed up by over £5m of funding from the HTA, BHF and NIHR to further develop this work in 3 separate trials: STOP-CKD, SPIRO-CKD and BARACK D. The CRIB-DONOR study, funded by the BHF, started recruiting in April 2011 and is investigating the effects of a small reduction in renal function in live kidney donors. This study will report in 2014 and is being followed up by an international study, EARNEST, also funded by the BHF.
- J - Inflammation
- J - Inflammation
- I - Immunology
- F - Endocrinology
- H - Haematology
- F - Endocrinology